13 January 2026
Clifford Chance advises on advanced surgical robotics company Edge Medical’s Chapter 18A IPO and Listing in Hong Kong
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Fang Liu Lead | Clifford Chance | Partner | Not stated | Not stated |
| Virginia Lee Lead | Clifford Chance | Partner | Not stated | Not stated |
| Janet Fok | Clifford Chance | Counsel | Not stated | Not stated |
| Ran Bi | Clifford Chance | Senior associate | Not stated | Not stated |
| Ryan Ho | Clifford Chance | Senior associate | Not stated | Not stated |
| Ruoyu Xiong | Clifford Chance | Associate | Not stated | Not stated |
| Choo Jun Kai | Clifford Chance | Associate | Not stated | Not stated |
| Phoebe Yan Ting Lo | Clifford Chance | Associate | Not stated | Not stated |
| Grace Wang | Clifford Chance | Associate | Not stated | Not stated |
| Minting Luo | Clifford Chance | Other | Not stated | Not stated |
| Carina Tan | Clifford Chance | Trainee | Not stated | Not stated |
| Pascal Chan | Clifford Chance | Other | Not stated | Not stated |
| Jay Lee | Clifford Chance | Other | Not stated | Not stated |
Stated terms
- Stated value
- HKD 1.20bn (HK$1.2 billion)
- What the figure measures
- Issue size
- Client
- Morgan Stanley, GF Capital, GF Securities, CICC, CLSA and CMBC SecuritiesUnderwriters
- Counterparties
- Shenzhen Edge Medical Co., Ltd. (Issuer)